Financial Health Assessment: RBDM LIMITED

1. Financial Health Score: F

Explanation: The patient is legally deceased. RBDM LIMITED currently holds a "Dissolved" company status, meaning it has ceased to operate and no longer exists as a legal corporate entity. While the final financial statements from 2022 showed some signs of short-term stabilization, the ultimate outcome for this business was terminal. A dissolved entity fundamentally cannot generate future revenue or recover from its long-term financial illnesses.

2. Key Vital Signs

• Heartbeat (Company Status): Dissolved. The company is no longer active. The corporate heartbeat has stopped, and the entity has been struck off the register.
• Blood Pressure (Working Capital): £552,403 (Positive). In its final year, the company saw a significant rally in its working capital, moving from a negative £27,734 in 2021 to a positive position. This indicated that short-term cash flow was temporarily stabilizing.
• Cholesterol/Toxins (Accumulated Deficit): -£13,067,798. The Profit & Loss account showed a massive accumulated deficit. This represents years of chronic financial bleeding and unprofitability that deeply poisoned the balance sheet.
• Immune System (Cash Reserves): £454,344. Cash at bank increased by roughly 58% from the prior year (£287,111), showing a temporary boost in liquidity before the company's closure.
• Surgical Intervention (Capital Reduction): Post-balance sheet events reveal a planned capital reduction to cancel nearly £8 million in preference shares. This was a major "surgical" procedure designed to restructure the balance sheet and absorb the massive P&L deficit.

3. Diagnosis

The financial data presents a classic case of a chronically ill patient experiencing a brief, misleading rally before terminal decline.

For years, RBDM LIMITED suffered from severe operational bleeding, evidenced by the £13 million accumulated deficit in the Profit and Loss reserve. This indicates that the cost of manufacturing and selling women's outerwear consistently outpaced revenues over the company's lifetime. The business only survived due to repeated "blood transfusions" from shareholders in the form of share capital and premium injections (over £13.9 million injected over the years).

In its final year (2022), the patient showed improved vital signs: cash increased, trade debtors grew (suggesting sales), and net current assets swung positive. Furthermore, the directors initiated major "surgery" by canceling preference shares to clean up the toxic P&L deficit. However, these positive indicators were ultimately a false recovery. The underlying business model was unsustainable, and the company was dissolved, with fashion designer Roksanda Ilincic listed as the ultimate controlling party. The dissolution suggests that even the restructuring efforts could not cure the core unprofitability of the enterprise.

4. Recommendations

Because the company is dissolved, traditional forward-looking business recommendations do not apply. However, for the directors, shareholders, and related parties, the following administrative and compliance actions are critical:

• Final Wound-Up Filings: Ensure that all final tax returns (Corporation Tax, VAT) are filed with HMRC and that any remaining liabilities are settled. Failure to do so can result in personal liability for directors.
• Settle Director Balances: The accounts show small outstanding balances owed to the company by directors (Roksanda Ilincic, Sian Westerman, and Jamie Gill). These must be settled before final distribution, or written off appropriately in the final tax return.
• Asset Distribution: Any remaining net assets (£898,904 at the 2022 year-end) legally belong to the shareholders. Proper legal procedures must be followed to distribute these assets and return capital to the owners (such as Eiesha Limited and Roksanda Ilincic).
• Protect Personal Credit: Directors should ensure that the dissolution is clean to avoid any risk of disqualification orders or future creditor claims that could "bite" their personal financial health.